Iscucin contains an extract from mistletoe plants. The semi-parasitic and epiphytic growing mistletoe is one of the most commonly used herbal ingredients. Its main area of application is in the treatment of cancer. While it has no direct influence on survival rates, it does improve mood and quality of life for cancer patients. It assigns to different forms of cancer, depending on the host tree from which the mistletoe has grown.
Mistletoe from the apple tree is mainly used in gynaecological tumours such as breast, ovarian and uterine cancer. In contrast, mistletoe by the poplar is used in prostate cancer. Mistletoe grown on pine is being considered for brain tumours. In lung cancer, the preparations vary depending on the origin of cancer cells: Squamous cell carcinomas are treated with mistletoe from the oak, and adenocarcinomas with mistletoe from lime. Iscucin Tiliae along with Iscucin Salicis (mistletoe from the willow) is used for kidney and bladder cancer. Tumours of the digestive tract (oesophagus, stomach, colorectal cancers) can be supportively treated with Iscucin Abietis (mistletoe from the pine). Mistletoe from the whitethorn is however not administered in cancer, but in vascular calcification.
It is applied subcutaneously, by which the preparation is injected under the skin. Preferably this should be performed by a doctor. Alternatively, mistletoe preparations can be injected directly into the cancer, where this is possible. This method of treatment should also be performed by a doctor. In principle, mistletoe therapy is well tolerated. However, redness, swelling and itching may occur at the injection site. Occasionally, allergic reactions are observed. Several studies on mistletoe therapy, however, showed a reduction in the side effects of chemotherapy.
Page 1 of 7 (80)